KDR and clear cell renal carcinoma: Although the treatment of metastatic clear cell renal cell carcinoma (mccRCC) has made great progress, vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors (TKIs) remain the first-line treatment worldwide [1].